| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131085A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/12/2001 | EP1131084A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 09/12/2001 | EP1131083A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 09/12/2001 | EP1131076A1 Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic |
| 09/12/2001 | EP1131069A1 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 09/12/2001 | EP1131063A2 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP1049481A4 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 09/12/2001 | EP0956028B1 Submucosal tissue inhibition of neoplastic cell growth |
| 09/12/2001 | EP0915845B1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 09/12/2001 | EP0817775B1 Quinazoline derivatives |
| 09/12/2001 | EP0809627B1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use |
| 09/12/2001 | EP0697885B1 Insulin-like growth factor ii as antitumour agent |
| 09/12/2001 | CN1312817A Dolastatin 15 derivatives |
| 09/12/2001 | CN1312807A Inhibitors of glycogen synthase kinase 3 |
| 09/12/2001 | CN1312804A Macrocyclic analogs and methods of their use and preparation |
| 09/12/2001 | CN1312803A Novel benzopykan or thiobenzopyran derivatives |
| 09/12/2001 | CN1312802A Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 09/12/2001 | CN1312725A Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312718A Selective estrogen receptor modulator in combination with sex steriod precursors and the like |
| 09/12/2001 | CN1312712A Therapeutic composition based on flavonoids for use in treatment of tumours with cytotoxic agents |
| 09/12/2001 | CN1312383A Human alpha-galactosidase A-11 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312381A Human cyclic AMP phosphodiesterase 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312372A Intocostrin regulation area and nucleotide series determination and method used thereof |
| 09/12/2001 | CN1312290A Human ribosome SII protein 12 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312287A Human zinc finger protein 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312283A Human cytochrome constituting protein 14 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312280A Human chromo structural domain containing protein 17 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312279A Human gamma-cop protein 16 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312275A Human heat shock protein 15 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312265A Human zine finger protein 10 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312261A Human proteinase regulating protein 11 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312260A Human proteinase regulating protein 10 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312254A Novel nucleoside |
| 09/12/2001 | CN1312253A Radde anemone rhizome extract and its prepn process and use |
| 09/12/2001 | CN1312116A Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method |
| 09/12/2001 | CN1312112A Cure-all ointment |
| 09/12/2001 | CN1312107A Cancer treating capsule and its preparation |
| 09/12/2001 | CN1312100A Tumor treating ointment |
| 09/12/2001 | CN1312099A Tumor-treating medicine |
| 09/12/2001 | CN1312072A Medicine composition for treating hepatocellular carcinoma |
| 09/12/2001 | CN1070866C Superagonists and antagonists and superantagonists of H IL-6, and 3-D modelling method for their selection |
| 09/11/2001 | US6288237 Plant protection. immunosuppression and/or be used to combat malignant tumours; they are particularily preferred as cytostatic agents. |
| 09/11/2001 | US6288228 Triazine angiogenesis inhibitors |
| 09/11/2001 | US6288115 Use of zinc salts of conjugated linoleic acids to treat skin disorders |
| 09/11/2001 | US6288111 Combination cisplatin/tamoxifen therapy for human cancers |
| 09/11/2001 | US6288110 Pharmaceutical compositions comprising disulfiram |
| 09/11/2001 | US6288107 Sulfatase inhibitors |
| 09/11/2001 | US6288078 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/11/2001 | US6288073 Acronycine derivatives, preparation method and pharmaceutical compositions |
| 09/11/2001 | US6288072 Anticarcinogenic and antitumor agents; leukemia |
| 09/11/2001 | US6288053 Use of protein kinase C inhibitors to enhance the clinical efficacy of radiation therapy |
| 09/11/2001 | US6288050 Steroid sulfatase inhibitors and methods for making and using the same |
| 09/11/2001 | US6288045 Administering 4,6 cyclo, trisilico, trimagnesium, trialumino, oxyo trihydrate acetate; side effect reduction |
| 09/11/2001 | US6288044 O-sulfated bacterial polysaccharides |
| 09/11/2001 | US6288035 Administering polypeptide as antitumor agent to treat melanoma; medical diagnosis |
| 09/11/2001 | US6288024 Methods and compositions for inhibiting angiogenesis |
| 09/11/2001 | US6287860 Antisense inhibition of MEKK2 expression |
| 09/11/2001 | US6287853 Genetically engineered escherichia plasmid; marking antibiotic resistance; artificial chromosomes; genetic mapping |
| 09/11/2001 | US6287802 EXT2 gene |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287602 Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent |
| 09/11/2001 | US6287599 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| 09/11/2001 | US6287593 Anticancer |
| 09/11/2001 | US6287563 Administering heat labile entertoxin |
| 09/11/2001 | US6287562 Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugates |
| 09/11/2001 | US6287556 Intracellular delivery vehicles |
| 09/11/2001 | CA2209422C 4-amino-3-acylnaphthyridine derivatives |
| 09/07/2001 | WO2001064944A1 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064904A2 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 09/07/2001 | WO2001064896A2 Human enzyme molecules |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064837A2 β NETRIN AND USES THEREOF |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064749A2 Method for preparing anti-mif antibodies |
| 09/07/2001 | WO2001064741A2 Methods for selectively modulating survivin apoptosis pathways |
| 09/07/2001 | WO2001064739A1 Tcf responsive element |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064737A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/07/2001 | WO2001064736A2 Proliferation arrest transcription factor and its use |
| 09/07/2001 | WO2001064733A1 A new polypeptide- human reverse transcription-related factor22 and the polynucleotide encoding it |
| 09/07/2001 | WO2001064721A1 A NOVEL POLYPEPTIDE-HUMAN ATPase 30 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 09/07/2001 | WO2001064707A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | WO2001064706A1 Antisense modulation of e2f transcription factor 1 expression |
| 09/07/2001 | WO2001064703A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/07/2001 | WO2001064696A1 Dicarboxylato diammine platinum derivatives and compositions comprising them as anti-tumor agents |
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064681A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064673A1 Flavone derivatives, preparation method and use as medicines |
| 09/07/2001 | WO2001064670A1 Novel cyclic amide derivatives |
| 09/07/2001 | WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | WO2001064668A2 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors |